Cite
HARVARD Citation
Dropmann, A. et al. (2020). TGF-β2 silencing to target biliary-derived liver diseases. Gut. 69 (9), pp. 1677-1690. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dropmann, A. et al. (2020). TGF-β2 silencing to target biliary-derived liver diseases. Gut. 69 (9), pp. 1677-1690. [Online].